FDAnews Drug Daily Bulletin

MGI PHARMA ANNOUNCES EXPIRATION OF TENDER OFFER FOR GUILFORD PHARMACEUTICALS NOTES DUE 2008

Nov. 30, 2005
A A

MGI PHARMA, INC. (Nasdaq:MOGN) announces results of its tender offer to purchase any and all of the outstanding 5% Convertible Subordinated Notes due July 1, 2008 of Guilford Pharmaceuticals Inc. (CUSIP Nos. 401829AA4 and 401829AB2 (the "Notes")). MGI PHARMA made the tender offer in connection with its wholly-owned subsidiary MGI GP, INC., formerly known as Guilford Pharmaceuticals Inc., as a result of the requirement to do so pursuant to the terms of the indenture under which the Notes were issued.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1114893XSL_NEWSML_TO_NEWSML_WEB.xml)